— Know what they know.
Not Investment Advice
Also trades as: IMU.AX (ASX) · $vol 0M

IUGNF OTC

Imugene Limited
1W: -28.6% 1M: -50.0% 3M: -58.4% YTD: -90.7% 1Y: -87.2% 3Y: -98.2% 5Y: -99.8%
$0.02
-0.00 (-10.75%)
 
Weekly Expected Move ±41.4%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 33 · $12.2M mcap · 278M float · 0.0098% daily turnover · Short 79% of daily vol

Balance Sheet Trends

Total Assets
$23M -72.5% ▼
5Y CAGR: -20.4%
Total Liabilities
$14M -63.7% ▼
5Y CAGR: +15.6%
Shareholders Equity
$9M -80.0% ▼
5Y CAGR: -32.7%
Cash & Investments
$3M -88.0% ▼
5Y CAGR: -38.3%
Total Debt
$6M -41.0% ▼
5Y CAGR: +87.6%
Net Debt
$4M +132.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$100M$153M$93M$22M$3M
Short-Term Investments$0$0$1M$0$0
Cash & ST Investments$100M$153M$95M$22M$3M
Net Receivables$13M$12M$13M$10M$2M
Inventory$0$0-$2M$0$4M
Other Current Assets$1M$402K$7M$6M$0
Total Current Assets$114M$166M$113M$42M$10M
Property, Plant & Equip.$863K$683K$2M$2M$131K
Goodwill & Intangibles$33M$30M$34M$32M$5M
Long-Term Investments$252K$218K$2M$225K$228K
Other Non-Current Assets$35K$19K$133K$8M$8M
Total Non-Current Assets$34M$31M$38M$42M$13M
Total Assets$148M$197M$151M$84M$23M
— Liabilities —
Accounts Payable$5M$2M$6M$7M$6M
Short-Term Debt$0$0$912K$7M$6M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$2M$3M$19M$3M$758K
Total Current Liabilities$7M$6M$29M$22M$14M
Long-Term Debt$0$0$0$3M$0
Other Non-Current Liab.$987K$991K$3M$14M$0
Total Non-Current Liabilities$1M$1M$4M$16M$0
Total Liabilities$9M$7M$33M$39M$14M
— Equity —
Common Stock$231M$314M$370M$381M$427M
Retained Earnings-$104M-$141M-$290M-$353M-$440M
Accumulated OCI$11M$17M$38M$17M$23M
Total Stockholders Equity$139M$190M$118M$45M$9M
Total Liabilities & Equity$148M$197M$151M$84M$23M
— Key Metrics —
Total Debt$673K$553K$2M$11M$6M
Net Debt-$99M-$153M-$92M-$11M$4M
Total Investments$252K$218K$4M$225K$228K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms